A nanoscale particle developed at MIT holds potential as a customizable delivery vehicle for personalized cancer vaccines. The particle could be adapted to carry many different antigens, to potentially treat individual patients’ tumors.

The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.